USFDA accepts biologics license application for GC Biopharma's GC5107B

Adlib and Generis launch software connector to increases automation and compliant management of document repositories

CARA is a data and content management platform that helps companies in regulated industries such as finance, energy, and manufacturing transform their complex business processes

Astellas receives FDA priority review for Zolbetuximab biologics license application

Astellas stands on the forefront of healthcare change to turn innovative science into value for patients

Aurobindo's subsidiary to withdraw application for EU marketing authorization of two biosimilars

This request for withdrawal of the two dossiers was made after necessary consultations and receiving guidance from EMA

InnoCan submits new patent applications for advanced pain relief technology

The application is in line with Innocan's strategy to expand the scope of its combined magnesium and cannabis topical solution

Astellas submits new drug application for Zolbetuximab in Japan

Ministry of Health, Labour and Welfare to evaluate zolbetuximab as treatment option for patients with advanced gastric and gastroesophageal cancers

Sure Med Compliance partners with Galt Phranchise Systems to support better outcomes in pain patients

Strategies aimed at solving the current overdose epidemic must go beyond the identification of risk

Evonik launches next-generation peptide for biopharma applications

One thousand times more soluble than L-cystine at neutral pH

HMD supplied 1.75 billion syringes of the total 13.3 billion COVID 19 vaccines administered globally

HMD had supplied 921.7 million syringes to the Government of India to facilitate over 2.2 billion Vaccination in India till date

USFDA lifts clinical hold on Phase 3 investigational new drug application for MaaT013

This is the first time the Agency has authorized the Phase 3 clinical evaluation in the U.S of a microbiota-based live biotherapeutic based on a pooling technology